DOWN BUT NOT OUT Based on the data so far, most scientists expect ivermectin to follow hydroxychloroquine into the dustbin of dubious medical claims. Nevertheless, there are still three large, randomized studies of the drug still ongoing, and some experts caution awaiting those results before ruling it out.
GETTY; NEWSWEEK; TOP RIGHT: BEATA ZAWRZEL/GETTY